Patents by Inventor KARIANNE GILLER FLETEN

KARIANNE GILLER FLETEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PACA and cabazitaxel for anti-cancer treatment
    Patent number: 11806330
    Abstract: Described herein is an active ingredient encapsulated into poly (alkyl cyanoacrylate) nanoparticles and their use in anti-cancer treatments by intraperitoneal administration.
    Type: Grant
    Filed: March 27, 2019
    Date of Patent: November 7, 2023
    Assignees: SINTEF TTO AS, OSLO UNIVERSITETSSYKEHUS HF
    Inventors: Yrr Morch, Einar Sulheim, Kjersti Flatmark, Karianne Giller Fleten, Per Stenstad, Heidi Johnsen, Ruth Schmid
  • DRUG DELIVERY SYSTEM FOR TREATMENT OF CANCER
    Publication number: 20220257525
    Abstract: Described herein is a hydrophobic anti-cancer drug encapsulated into poly (alkyl cyanoacrylate) nanoparticles and their use in cancer treatments by intracavitary rout of administration such as intraperitoneal administration.
    Type: Application
    Filed: September 24, 2021
    Publication date: August 18, 2022
    Inventors: Yrr MORCH, Ruth SCHMID, Einar SULHEIM, Per STENSTAD, Heidi JOHNSEN, Kjersti FLATMARK, Karianne Giller FLETEN
  • DRUG DELIVERY SYSTEM FOR TREATMENT OF CANCER
    Publication number: 20200061019
    Abstract: Described herein is a hydrophobic anti-cancer drug encapsulated into poly (alkyl cyanoacrylate) nanoparticles and their use in cancer treatments by intracavitary rout of administration such as intraperitoneal administration.
    Type: Application
    Filed: November 12, 2019
    Publication date: February 27, 2020
    Inventors: Yrr Morch, Einar Sulheim, KJersti Flatmark, Karianne Giller Fleten, Per Stenstad, Heidi Johnsen, Ruth Schmid
  • PACA AND CABAZITAXEL FOR ANTI-CANCER TREATMENT
    Publication number: 20190298682
    Abstract: Described herein is an active ingredient encapsulated into poly (alkyl cyanoacrylate) nanoparticles and their use in anti-cancer treatments by intraperitoneal administration.
    Type: Application
    Filed: March 27, 2019
    Publication date: October 3, 2019
    Inventors: YRR MORCH, EINAR SULHEIM, KJERSTI FLATMARK, KARIANNE GILLER FLETEN, Per Stenstad, Heidi Johnsen, Ruth Schmid